Jublin-M Capsule is a combination pharmaceutical formulation containing Methylcobalamin 750 mcg and Pregabalin 75 mg, indicated for the management of neuropathic pain and related neurological disorders. Methylcobalamin, an active form of vitamin B12, plays a crucial role in nerve regeneration and repair by promoting myelin sheath synthesis and supporting neuronal metabolism. Pregabalin, an anticonvulsant and analgesic agent, modulates calcium channel function in the central nervous system, thereby reducing the release of excitatory neurotransmitters involved in pain transmission. The synergistic effect of these components provides effective relief from neuropathic pain associated with diabetic neuropathy, postherpetic neuralgia, and other peripheral neuropathies, while also improving nerve function and sensory perception. Jublin-M Capsule is typically administered orally, with dosage tailored according to the severity of symptoms and patient response. Common adverse effects may include dizziness, somnolence, and gastrointestinal disturbances; therefore, caution is advised in patients with renal impairment or a history of hypersensitivity. Jublin-M should be used under medical supervision, ensuring appropriate monitoring to optimize therapeutic outcomes and minimize potential side effects. This combination therapy offers a comprehensive approach to neuropathic pain management by addressing both symptom relief and nerve health restoration.